Patient Lifestyle

In speaking with a patient nearing end of life, I’m reminded of how important it is to go beyond the “written” directives.

Researchers found the waning in effectiveness holds true even after boosters.

In the 18-month trial, people in the early stages of Alzheimer’s who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug.

Even after years research, there's no conclusive evidence of efficacy or safety in treating acute back pain.

The U.S. Food and Drug Administration decision makes GSK’s shot, called Arexvy, the first of several potential vaccines in the pipeline for RSV to be licensed anywhere.

Update from the American College of Gastroenterology aimed at supporting clinical practice.

Research shows that Americans, who have become less engaged with worship houses, community organizations and even their own family members in recent decades, have steadily reported an increase in feelings of loneliness.